January 20, 2022
HLAA Webinar: Potential New Therapies and Clinical Trial Opportunities for Sudden and Noise-Induced Sensorineural Hearing Loss
- Presenter(s)
- Carl LeBel, Ph.D.
- Grace Fitzgerald
Are you interested in learning about new, emerging therapies that could potentially restore hearing? Would you like to stay apprised of new clinical trials for individuals with sensorineural hearing loss...Are you interested in learning about new, emerging therapies that could potentially restore hearing? Would you like to stay apprised of new clinical trials for individuals with sensorineural hearing loss (SNHL) – and learn how to enroll? In this program, Frequency Therapeutics’ Chief Development Officer, Dr. Carl LeBel, provided an overview of outcomes from four completed clinical trials of FX-322, the Company’s product candidate, which is the first to have... Read More >